⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

PHAT

Phathom Pharmaceuticals, Inc.

Healthcare · Biotechnology

6.22USD

-0.0600 (-0.96%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on PHAT.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End09/2026 Q3
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 6.22
P/E—
Dvd Ind Yld0.0%
P/B—
P/S1.8
Curr EV/T12M EBITDA-21.7
Mkt Cap (USD)0.5B
Curr EV (USD)0.9B
2)

Per Share Data

EPS T12M-1.03
DPS—
Bk Val Per Sh-4.30
Rev/Sh3.24
Cash/Sh2.26
Curr Shares Out80.9M
FCF/Sh-0.25
3)

Cash Flow Analysis

P/CF-24.3
Curr P/FCF-23.9
CF/NI0.2
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-7.5%
Eff Interest Rate33.7%
4)

Growth Potential

Dil EPS 1Y Gr42.7%
Cap 1Y Gr-339.1%
BPS 1Y Gr-49.7%
R&D To Sales11.6%
Retention Rate—
Rev 1Y Gr216.9%
FCF 1Y Gr37.4%
Assets 1Y Gr-31.5%
5)

Profitability

EBITDA-0.0B
EBIT-0.0B
Operating Margin-9.3%
Pretax Margin-80.5%
Net Margin-30.2%
ROA-28.4%
ROE21.6%
ROC14.0%
Asset Turnover0.94
6)

Structure

Current Ratio1.76
Quick Ratio1.82
Debt/Assets48.0%
Debt/Com Eq-47.6%
Net Debt/EBITDA0.76
Tot Debt/Capital-90.9%
Gross Margin80.7%
EBIT/Int Exp-0.4

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.